Overview

Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatmen

Status:
Unknown status
Trial end date:
2010-07-01
Target enrollment:
0
Participant gender:
Female
Summary
This study was designed to evaluate the ability of gonadotropin releasing hormone (GnRh) agonist to prevent the rise of progesterone during controlled ovarian stimulation for in vitro fertilization (IVF) after the administration of human Chorionic Gonadotropin (hCG) on the first day of menses.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Chorionic Gonadotropin
Deslorelin
Goserelin
Hormones
Luteolytic Agents
Triptorelin Pamoate
Criteria
Inclusion Criteria:

- age >21 and < 38 years old

- polycystic ovarian syndrome

- risk for ovarian hyperstimulation syndrome

Exclusion Criteria:

- recurrent abortion

- endometriosis

- more than 3 IVF failures

- use of oral contraceptive pills in the preceding 3 months

- low response to gonadotropins